1. Home >
  2. M&A >
  3. Stake Purchase >
  4. Canada >
  5. Ontario >
  6. Oracle Investment Management Invests In Transition Therapeutics

Investment Summary

Oracle Investment Management Invests In Transition Therapeutics

On June 6, 2014, private equity firm Oracle Investment Management invested in life science company Transition Therapeutics

Investment Highlights
  • This is Oracle Investment Management’s 1st transaction in the Life Science sector.
  • This is Oracle Investment Management’s 1st transaction in Canada.
  • This is Oracle Investment Management’s 1st transaction in Ontario.
Investment Fate
  • Transition Therapeutics was sold to a strategic buyer in 2016 for 60M USD.

Investment Summary
Date 2014-06-06
Target Transition Therapeutics
Sector Life Science
Investor(s) Oracle Investment Management
Deal Type Stake Purchase

Target

Transition Therapeutics

Toronto, Ontario, Canada
Transition Therapeutics Inc. is a bio pharmaceutical company, develops therapeutics for various disease indications. Transition Therapeutics, Inc. was formed in 1987 and is based in Toronto, Ontario.

Search 214,876 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Oracle Investment Management

Greenwich, Connecticut, United States
Category Private Equity Firm
Founded 1993
Size Middle-Market
Type Sector Focused
DESCRIPTION

Oracle Investment Management is a specialist alternative investor focused on opportunities in the global healthcare and bio science industries. Oracle was formed its first partnership in 1993 and is based in Greenwich, Connecticut.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2014 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal